Biology Reference
In-Depth Information
[22] Lindner H, Holler E, Gerbitz A, Johnson JP, Bornkamm GW, Eissner G. Influence of
bacterial endotoxin on radiation-induced activation of human endothelial cells in vitro
and in vivo : interleukin-10 protects against transendothelial migration. Transplantation
1997;64(9):1370-3.
[23] Eissner G, Kohlhuber F, Grell M, Ueffing M, Scheurich P, Hieke A, et al. Critical involve-
ment of transmembrane tumor necrosis factor-alpha in endothelial programmed cell
death mediated by ionizing radiation and bacterial endotoxin. Blood 1995;86(11):4184-93.
[24] Woywodt A, Scheer J, Hambach L, Buchholz S, Ganser A, Haller H, et al. Circulating
endothelial cells as a marker of endothelial damage in allogeneic hematopoietic stem
cell transplantation. Blood 2004;103(9):3603-5.
[25] Palomo M, Diaz-Ricart M, Carbo C, Rovira M, Fernandez-Aviles F, Escolar G, et al.
The release of soluble factors contributing to endothelial activation and damage
after hematopoietic stem cell transplantation is not limited to the allogeneic set-
ting and involves several pathogenic mechanisms. Biol Blood Marrow Transplant
2009;15(5):537-46.
[26] Penack O, Sociá G, van den Brink MR. The importance of neovascularization
and its inhibition for allogeneic hematopoietic stem cell transplantation. Blood
2011;117(16):4181-9.
[27] Penack O, Henke E, Suh D, King CG, Smith OM, Na IK, et al. Inhibition of neovascular-
ization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth. J
Natl Cancer Inst 2010;102(12):894-908.
[28] Willemze AJ, Bakker AC. von dem Borne PA, Bajema IM, Vossen JM. The effect of graft-
versus-host disease on skin endothelial and epithelial cell chimerism in stem-cell trans-
plant recipients. Transplantation 2009;87(7):1096-101.
[29] Hallahan D, Kuchibhotla J, Wyble C. Cell adhesion molecules mediate radiation-induced
leukocyte adhesion to the vascular endothelium. Cancer Res 1996;56(22):5150-5.
[30] Hallahan DE, Spriggs DR, Beckett MA, Kufe DW, Weichselbaum RR. Increased tumor
necrosis factor alpha mRNA after cellular exposure to ionizing radiation. Proc Natl Acad
Sci USA 1989;86(24):10104-7.
[31] Behrends U, Peter RU, Hintermeier-Knabe R, Eissner G, Holler E, Bornkamm GW, et al.
Ionizing radiation induces human intercellular adhesion molecule-1 in vitro . J Invest
Dermatol 1994;103(5):726-30.
[32] Holler E, Kolb HJ, Hintermeier-Knabe R, Mittermüller J, Thierfelder S, Kaul M, et al.
Role of tumor necrosis factor alpha in acute graft-versus-host disease and complications
following allogeneic bone marrow transplantation. Transplant Proc 1993;
25(1 Pt 2):1234-6.
[33] Holler E, Kolb HJ, Möller A, Kempeni J, Liesenfeld S, Pechumer H, et al. Increased serum
levels of tumor necrosis factor alpha precede major complications of bone marrow
transplantation. Blood 1990;75(4):1011-6.
[34] Holler E, Kolb HJ, Mittermüller J, Kaul M, Ledderose G, Duell T, et al. Modulation of
acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor
necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning:
role of conditioning regimens and prophylactic application of a monoclonal antibody
neutralizing human TNF alpha (MAK 195F). Blood 1995;86(3):890-9.
[35] Choi SW, Stiff P, Cooke K, Ferrara JL, Braun T, Kitko C, et al. TNF-inhibition with
etanercept for graft-versus-host disease prevention in high-risk HCT: lower TNFR1 levels
correlate with better outcomes. Biol Blood Marrow Transplant 2012 Mar 30. (Epub ahead
of print).
[36] Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet 2009;
373(9674):1550-61.
[37] Chakraverty R, Sykes M. The role of antigen-presenting cells in triggering graft-versus-
host disease and graft-versus-leukemia. Blood 2007;110(1):9-17.
[38] Haniffa M, Ginhoux F, Wang XN, Bigley V, Abel M, Dimmick I, et al. Differential rates of
replacement of human dermal dendritic cells and macrophages during hematopoietic
stem cell transplantation. J Exp Med 2009;206(2):371-85.
[39] Collin MP, Hart DN, Jackson GH, Cook G, Cavet J, Mackinnon S, et al. The fate of
human Langerhans cells in hematopoietic stem cell transplantation. J Exp Med
2006;203(1):27-33.
[40] Turner BE, Kambouris ME, Sinfield L, Lange J, Burns AM, Lourie R, et al. Reduced
intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the
kinetics of acute graft-versus-host disease. Transplantation 2008;86(7):968-76.
[41] Li H, Matte-Martone C, Tan HS, Venkatesan S, McNiff J, Demetris AJ, et al. Graft-versus-
host disease is independent of innate signaling pathways triggered by pathogens in host
hematopoietic cells. J Immunol 2011;186(1):230-41.
[42] Zeiser R, Penack O, Holler E, Idzko M. Danger signals activating innate immunity in
graft-versus-host disease. J Mol Med (Berl) 2011;89(9):833-45.
170
Search WWH ::




Custom Search